作者: Gregory Egan , Glen J. Pearson
关键词:
摘要: For heart transplant patients, there are a number of non-immunosuppressant medications that routinely prescribed to mitigate the side-effects immunosuppression, treat related complications, and improve long-term survival. This review focuses on used prevent manage cardiac allograft vasculopathy (CAV), hypertension, dyslipidemia osteoporosis. The rationale evidence supporting their use summarized immunosuppressant drugs only discussed briefly, as they relate each these medical issues. Pharmacy practitioners likely encounter patients post-cardiac in variety clinical settings; therefore, concise appreciation principles for management is important when providing collaborative care.